Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Specific immunotherapy ameliorates ulcerative colitis

Fig. 1

Patients completed the 6 month therapy. In total 102 UC patients were recruited into this study. The patients were randomly divided into four groups. Among them, two patients withdrew for SIT adverse reaction; one withdrew for IBD symptom exaggerated; three withdrew for personal reasons. Thus, 96 patients completed the 6 month therapy

Back to article page

Allergy, Asthma & Clinical Immunology

ISSN: 1710-1492

Contact us